|
|
|
Volumn 60, Issue 2, 1997, Pages 265-271
|
|
Polymorphisms in drug-metabolizing enzymes: What is their clinical relevance and why do they exist?
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
DRUG METABOLIZING ENZYME;
GLUCOSE 6 PHOSPHATE DEHYDROGENASE;
ACETYLATION;
DISEASE ASSOCIATION;
EDITORIAL;
ETHICS;
GENE LOCATION;
GENETIC POLYMORPHISM;
PHENOTYPE;
PRIORITY JOURNAL;
ACETYLATION;
ANIMALS;
ARYLAMINE N-ACETYLTRANSFERASE;
BIOETHICS;
CYTOCHROME P-450 CYP2D6;
DEBRISOQUIN;
DIET;
DISEASE SUSCEPTIBILITY;
ETHNIC GROUPS;
GLUCOSEPHOSPHATE DEHYDROGENASE;
HUMANS;
NEOPLASMS;
OXIDATION-REDUCTION;
POLYMORPHISM, GENETIC;
|
|
EID: 0031035007
PISSN: 00029297
EISSN: None
Source Type: Journal
DOI: None Document Type: Editorial |
|
Times cited : (240)
|
|
References (31)
|
